We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 19, 2019

Cost-Effectiveness of Transcatheter Mitral Valve Repair vs Medical Therapy in the COAPT Trial



Additional Info

Disclosure statements are available on the authors' profiles:

Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial
Circulation 2019 Sep 29;[EPub Ahead of Print], SJ Baron, K Wang, SV Arnold, EA Magnuson, B Whisenant, A Brieke, M Rinaldi, AW Asgar, J Lindenfeld, WT Abraham, MJ Mack, GW Stone, DJ Cohen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading